WallStreetZenWallStreetZen

NYSE: ZTS
Zoetis Inc Earnings & Revenue

ZTS past earnings growth

How has ZTS's earnings growth performed historically?
Company
5.28%
Industry
4.14%
Market
36.76%
ZTS's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
ZTS's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
ZTS's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

ZTS past revenue growth

How has ZTS's revenue growth performed historically?
Company
5.13%
Industry
228.76%
Market
163.96%
ZTS's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ZTS's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ZTS's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ZTS earnings and revenue history

Current Revenue
$8.0B
Current Earnings
$2.1B
Current Profit Margin
25.8%

ZTS Return on Equity

Current Company
44.8%
Current Industry
12.4%
Current Market
-8.3%
ZTS's Return on Equity (44.8%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ZTS announces earnings.

ZTS Return on Assets

Current Company
15%
Current Industry
3.8%
ZTS is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ZTS Return on Capital Employed

Current Company
25.81%
Current Industry
7.9%
ZTS has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ZTS vs Pharmaceutical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ZTS$8.01B$3.25B$2.07B+9.34%+18.11%
TAK$45.17B$11.50B$3.72B+28.50%+16.42%
VTRS$16.73B$4.64B$803.60M+6.98%-16.95%
TEVA$15.14B$191.00M-$1.29B-5.72%N/A
CTLT$4.83B$1.03B$421.00M+17.25%+21.71%

ZTS earnings dates

Next earnings date
Feb 14, 2023

Zoetis Earnings & Revenue FAQ

What were ZTS's earnings last quarter?

On Invalid Date, Zoetis (NYSE: ZTS) reported Q3 2022 earnings per share (EPS) of $1.13, up 2.59% year over year. Total Zoetis earnings for the quarter were $529.00 million. In the same quarter last year, Zoetis's earnings per share (EPS) was $1.16.

If you're new to stock investing, here's how to buy Zoetis stock.

What was ZTS's earnings growth in the past year?

As of Q1 2023, Zoetis's earnings has grown 5.28% year over year. This is 1.14 percentage points higher than the US Drug Manufacturers - Specialty & Generic industry earnings growth rate of 4.14%. Zoetis's earnings in the past year totalled $2.07 billion.

What is ZTS's earnings date?

Zoetis's earnings date is Invalid Date. Add ZTS to your watchlist to be reminded of ZTS's next earnings announcement.

What was ZTS's revenue last quarter?

On Invalid Date, Zoetis (NYSE: ZTS) reported Q3 2022 revenue of $2.00 billion up 0.6% year over year. In the same quarter last year, Zoetis's revenue was $1.99 billion.

What was ZTS's revenue growth in the past year?

As of Q1 2023, Zoetis's revenue has grown 5.13% year over year. This is 223.62 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 228.76%. Zoetis's revenue in the past year totalled $8.01 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.